NK1 Receptor Antagonist vs Placebo in the Treatment of Overactive Bladder Symptoms
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Casopitant (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 04 Apr 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
- 08 Nov 2006 New trial record.